The future of cancer research is today.

The Fred & Pamela Buffett Cancer Center will change forever the way cancer is diagnosed and treated by harnessing the most advanced biomedical and technological tools available, we will better identify the drivers behind cancer and create precise therapies that improve outcomes. Through the use of genomics and other new diagnostic tools, we will employ precision medicine to customize therapies and care for each cancer patient.

While all forms of cancer will be treated at the Fred & Pamela Buffett Cancer Center, because of their prevalence in society and the center’s potential to have a significant impact in their treatment, the following focus areas have been selected: Breast Cancer and Other Women’s Cancers, Head and Neck Cancers, Leukemia and Lymphoma, Lung Cancer, Pancreatic and Gastrointestinal Cancers, and Prostate Cancer.

Learn More

 

Virtually every human disease is rooted in our genes. For many years, scientists have understood that genetics are linked to birth defects and diseases like cystic fibrosis, Huntington’s and muscular dystrophy. They had a simple, predictable inheritance pattern caused by a change in a single gene.

Today, we know cancer is more complex – but may be just as predictable. Many genetic mutations drive a cancer. By mapping and profiling these alterations through genomics – studying all the genes in a person and how they interact – the Fred & Pamela Buffett Cancer Center will produce revolutionary cancer therapies personalized for each patient’s specific cancer.

Regenerative Medicine is an emerging interdisciplinary field of research. The clinical applications resulting from this field focus on the repair, replacement or regeneration of cells, tissues, or organs to restore lost function. Cancer is an uncontrolled division of abnormal cells so by identifying what controls cell growth we can stop the process in its tracks, thus changing the fate of the cell.
Translational research is the process of translating scientific findings into therapeutic interventions. Researchers study a disease in the lab and develop tools for physicians to try in clinical trials while clinicians chart the effects in patients, which in turn, impacts research efforts. Referred to as the bench-to-bedside approach, patients receive effective treatments as quickly as possible.

The Fred & Pamela Buffett Cancer Center has a team of scientists solely devoted to researching cancer and drug development. This clinical research is spurring new and innovative approaches to prevention, early detection, diagnosis and treatment of cancer.

Also called clinical studies or clinical trials, clinical cancer research involves people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and aid in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts.
Associate Directors
External Advisory Board
Research Program Leaders